BAX Stock Overview
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Baxter International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$40.13 |
| 52 Week High | US$50.21 |
| 52 Week Low | US$31.01 |
| Beta | 0.63 |
| 1 Month Change | -6.11% |
| 3 Month Change | 2.69% |
| 1 Year Change | -15.83% |
| 3 Year Change | -53.17% |
| 5 Year Change | -48.09% |
| Change since IPO | 2,966.65% |
Recent News & Updates
Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal
Apr 14
Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts
Feb 23Recent updates
Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal
Apr 14Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts
Feb 23Baxter International's (NYSE:BAX) Dividend Will Be $0.29
Feb 20Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden
Jan 28Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital
Jan 12Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares
Dec 28Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield
Dec 12Estimating The Fair Value Of Baxter International Inc. (NYSE:BAX)
Nov 27Is Baxter International (NYSE:BAX) A Risky Investment?
Oct 27Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?
Oct 12There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital
Sep 21Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
Aug 23Dividend Challengers Review: Baxter International
Aug 14Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
Jul 25Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet
Jul 14Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF
Jun 12Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture
Jun 07Baxter International's (NYSE:BAX) Dividend Will Be $0.29
May 19Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
May 05Baxter International Inc.'s (NYSE:BAX) Intrinsic Value Is Potentially 26% Above Its Share Price
Apr 24Is Baxter International (NYSE:BAX) Using Too Much Debt?
Apr 03Baxter International's (NYSE:BAX) Dividend Will Be $0.29
Feb 18Investors Could Be Concerned With Baxter International's (NYSE:BAX) Returns On Capital
Feb 10Baxter International: Another YoY Earnings Decline Expected, Shares Tag Support
Feb 03Why Baxter Is One Of My #1 2023 Bets For Healthcare/Medtech
Jan 02An Intrinsic Calculation For Baxter International Inc. (NYSE:BAX) Suggests It's 32% Undervalued
Dec 30Baxter cut to hold at Deutsche Bank on inflation pressures
Dec 15Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
Nov 18Baxter International: Despite Weakening On The Bottom Line, Shares Look Attractive
Oct 24Here's What's Concerning About Baxter International's (NYSE:BAX) Returns On Capital
Oct 05Baxter is said to evaluate sale of two of its kidney businesses
Sep 14Baxter reaches 52-week low; stock down 34% YTD
Aug 29Shareholder Returns
| BAX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.7% | 2.1% | 2.9% |
| 1Y | -15.8% | -1.9% | 22.2% |
Return vs Industry: BAX underperformed the US Medical Equipment industry which returned -1.9% over the past year.
Return vs Market: BAX underperformed the US Market which returned 22.2% over the past year.
Price Volatility
| BAX volatility | |
|---|---|
| BAX Average Weekly Movement | 3.3% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BAX has not had significant price volatility in the past 3 months.
Volatility Over Time: BAX's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1931 | 60,000 | Joe Almeida | www.baxter.com |
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.
Baxter International Inc. Fundamentals Summary
| BAX fundamental statistics | |
|---|---|
| Market cap | US$20.44b |
| Earnings (TTM) | -US$76.00m |
| Revenue (TTM) | US$14.81b |
1.4x
P/S Ratio-268.9x
P/E RatioIs BAX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BAX income statement (TTM) | |
|---|---|
| Revenue | US$14.81b |
| Cost of Revenue | US$9.15b |
| Gross Profit | US$5.66b |
| Other Expenses | US$5.74b |
| Earnings | -US$76.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 38.22% |
| Net Profit Margin | -0.51% |
| Debt/Equity Ratio | 162.1% |
How did BAX perform over the long term?
See historical performance and comparison